203 related articles for article (PubMed ID: 26884118)
21. 68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level.
Nicolini S; Ambrosini V; Fantini L; Fanti S
Clin Nucl Med; 2012 Jun; 37(6):591-2. PubMed ID: 22614194
[TBL] [Abstract][Full Text] [Related]
22. Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.
Gotthardt M; Béhé MP; Beuter D; Battmann A; Bauhofer A; Schurrat T; Schipper M; Pollum H; Oyen WJ; Behr TM
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1273-9. PubMed ID: 16832634
[TBL] [Abstract][Full Text] [Related]
23. The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
Golubić AT; Pasini Nemir E; Žuvić M; Mutvar A; Kusačić Kuna S; Despot M; Samardžić T; Huić D
Nucl Med Commun; 2017 Jul; 38(7):636-641. PubMed ID: 28562377
[TBL] [Abstract][Full Text] [Related]
24. Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
De Luca S; Fonti R; Camera L; Salvatore B; Faggiano A; Ciarmiello A; Segreto S; Colao A; Salvatore M; Del Vecchio S
Ann Nucl Med; 2016 Apr; 30(3):234-41. PubMed ID: 26753628
[TBL] [Abstract][Full Text] [Related]
25. Thyroid carcinoma metastasizing to the submandibular gland: Sonographic findings.
Golant BT; Velez-Perez A; Krishnamurthy S; Guo M; Mousavi S; Hu MI; Varghese JM; Zafereo ME; Debnam JM
J Clin Ultrasound; 2020 May; 48(4):227-230. PubMed ID: 32045024
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and Therapeutic Uptake of Intrathyroid Metastasis of Midgut Neuroendocrine Tumor on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE Imaging.
Vija Racaru L; Sinigaglia M; Fontaine S; DʼAure D; Courbon F; Dierickx L
Clin Nucl Med; 2019 Jul; 44(7):e445-e448. PubMed ID: 31021912
[TBL] [Abstract][Full Text] [Related]
27. (18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
Archier A; Heimburger C; Guerin C; Morange I; Palazzo FF; Henry JF; Schneegans O; Mundler O; Abdullah AE; Sebag F; Imperiale A; Taïeb D
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1027-33. PubMed ID: 26497699
[TBL] [Abstract][Full Text] [Related]
28. Positron Emission Tomography Imaging in Medullary Thyroid Carcinoma: Time for Reappraisal?
Castinetti F; Taïeb D
Thyroid; 2021 Feb; 31(2):151-155. PubMed ID: 33191866
[TBL] [Abstract][Full Text] [Related]
29. Thyroid Incidentaloma on 18F-fluorocholine PET/CT and 68Ga-PSMA PET/CT Revealing a Medullary Thyroid Carcinoma.
Ciappuccini R; Edet-Sanson A; Saguet-Rysanek V; Gauthé M; Bardet S
Clin Nucl Med; 2019 Aug; 44(8):663-665. PubMed ID: 31274618
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of [
Jamsek J; Hocevar M; Bergant D; Zaletel K; Rep S; Lezaic L
Ann Nucl Med; 2021 Apr; 35(4):429-437. PubMed ID: 33544320
[TBL] [Abstract][Full Text] [Related]
31. Sentinel node radioguided biopsy in surgical management of the medullary thyroid carcinoma A case report.
Boni G; Mazzarri S; Grosso M; Manca G; Biricotti M; Ambrosini CE; Fregoli L; Puccini M; Caldarelli C; Spisni R
Ann Ital Chir; 2014 Jan; 85(ePub):. PubMed ID: 24556598
[TBL] [Abstract][Full Text] [Related]
32.
Yamaga LYI; Cunha ML; Campos Neto GC; Garcia MRT; Yang JH; Camacho CP; Wagner J; Funari MBG
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1695-1701. PubMed ID: 28429044
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Challenges of Medullary Thyroid Carcinoma.
Leimbach RD; Hoang TD; Shakir MKM
Oncology; 2021; 99(7):422-432. PubMed ID: 33878761
[TBL] [Abstract][Full Text] [Related]
34. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
35. [
Rasul S; Hartenbach S; Rebhan K; Göllner A; Karanikas G; Mayerhoefer M; Mazal P; Hacker M; Hartenbach M
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2159-2169. PubMed ID: 29766245
[TBL] [Abstract][Full Text] [Related]
36. Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.
Herac M; Niederle B; Raderer M; Krebs M; Kaserer K; Koperek O
APMIS; 2016 Oct; 124(10):839-45. PubMed ID: 27539746
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
38. Radioguided hepatic resection with
López-Gómez J; Medina-Ornelas S; Salazar-Álvarez MA; Álvarez-Bojórquez M; Zaragoza-Cruz N; Melchor-Ruan J; Álvarez-Cano A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):244-249. PubMed ID: 29754940
[TBL] [Abstract][Full Text] [Related]
39. Concomitant medullary thyroid carcinoma with paraganglioma-like pattern and papillary thyroid carcinoma.
Greco C; Brigante G; Taliani E; Corrado S; Simoni M; Madeo B
Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31778356
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]